TGFB1 and cancer: In addition, emodin significantly reduced both baseline peritoneal macrophage-conditioned medium (PMCM) treatment-induced TGF-β1 production in cancer cells and TGF-β1 induced Arg-1 expression, which has been shown to define immunosuppressive subsets of TAMs.